Efficacy of Baricitinib in the Treatment of Chilblains Associated With the Type I Interferonopathy Aicardi-Goutières Syndrome
Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40805
Full Text
Open PDFAbstract
Available in full text
Date
March 6, 2019
Authors
Publisher
Wiley